Case Report

Methylphenidate-Induced Menorrhagia in Twin Girls

Abstract

Objective: Methylphenidate, a psychostimulant agent, is used in first-line psychopharmacological treatment in children and adolescents with attention-deficit/hyperactivity disorder. Common side effects associated with methylphenidate use in children and adolescents are insomnia, anorexia, headache, and nausea. Thrombocytopenia, nasal bleeding and menstrual bleeding disorders are very rarely reported during methylphenidate use. One of the least expected side effects during methylphenidate usage is menorrhagia.

Method: In this article, we report methylphenidate monotherapy-induced menorrhagia in two adolescent identical twins. To our knowledge, this is the first report of menorrhagia associated with methylphenidate use in children and adolescents.

Results: In both cases, menorrhagia has started after methylphenidate monotherapy and stopped after discontinuation. Other possible etiologies have excluded with clinical and laboratory evaluations. Naranjo Adverse Drug Reaction Probability Score was found 7, indicates probable side effect.

Conclusion: Menorrhagia is a rare adverse effect of methylphenidate use and clinicians should be aware of this phenomenon.

1. Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018;5(5):Cd012069.
2. Coskun M, Adak I. Excessive and Frequent Menstrual Bleeding With Methylphenidate in an Adolescent Girl With Attention-Deficit Hyperactivity Disorder. J Clin Psychopharmacol. 2017;37(5):637-9.
3. Mutlu C, Bahalı K, Gunes H, Adaletli H. Increase in Menstrual Cycle Length Induced by Extended-Release Methylphenidate in an Adolescent with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2016;26(9):860-1.
4. Ercan ES, Inci SB, Ipci M. Is There an Effect of Methylphenidate on Thrombocytopenia? J Clin Psychopharmacol. 2017;37(3):374.
5. Chandradasa M, Rathnayake LC. Immediate-Release Methylphenidate-Associated Recurrent Nasal Bleeding in Siblings. J Clin Psychopharmacol. 2019;39(3):284-5.
6. Ahuja SP, Hertweck SP. Overview of bleeding disorders in adolescent females with menorrhagia. J Pediatr Adolesc Gynecol. 2010;23(6 Suppl):S15-21.
7. Schedel A, Schloss P, Klüter H, Bugert P. The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 2008;378(4):431-9.
8. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45.
Files
IssueVol 17 No 4 (2022) QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/ijps.v17i4.10698
Keywords
Adverse Effects Adolescent Menorrhagia Methylphenidate
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Özdağ V, Koyuncu O, Özdemir YE, Tanir Y. Methylphenidate-Induced Menorrhagia in Twin Girls. Iran J Psychiatry. 2022;17(4):476-479.